N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C132H137ClF15N25O13 — CID 165047205

IUPACN-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)ccc3n2)C1.CC(C)(O)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(Cl)cc3n2)C1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)c1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cnn2cccnc12.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CC(CO)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C24H26F3N3O2.C23H26N6O2.C22H23F3N4O3.C22H23F3N4O.C21H20ClF3N4O2.C20H19F3N4O3/c1-23(2,3)17-10-18(11-17)30-13-15-9-20(21(32-4)12-19(15)29-30)28-22(31)14-6-5-7-16(8-14)24(25,26)27;1-23(2,3)15-9-16(10-15)29-13-14-8-19(20(31-4)11-18(14)27-29)26-22(30)17-12-25-28-7-5-6-24-21(17)28;1-21(2,31)13-8-14(9-13)29-11-12-7-17(18(32-3)10-16(12)28-29)27-20(30)15-5-4-6-19(26-15)22(23,24)25;1-21(2,3)14-10-16(11-14)29-12-13-9-15(7-8-17(13)28-29)26-20(30)18-5-4-6-19(27-18)22(23,24)25;1-20(2,31)12-7-13(8-12)29-10-11-6-17(14(22)9-16(11)28-29)27-19(30)15-4-3-5-18(26-15)21(23,24)25;1-30-17-8-15-12(9-27(26-15)13-5-11(6-13)10-28)7-16(17)25-19(29)14-3-2-4-18(24-14)20(21,22)23/h5-9,12-13,17-18H,10-11H2,1-4H3,(H,28,31);5-8,11-13,15-16H,9-10H2,1-4H3,(H,26,30);4-7,10-11,13-14,31H,8-9H2,1-3H3,(H,27,30);4-9,12,14,16H,10-11H2,1-3H3,(H,26,30);3-6,9-10,12-13,31H,7-8H2,1-2H3,(H,27,30);2-4,7-9,11,13,28H,5-6,10H2,1H3,(H,25,29)
InChIKeyPCDIPBMXUUSYFU-UHFFFAOYSA-N
MW2602.13 g/mol
LogP29.52
Rot. Bonds25

About N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 165047205) has the molecular formula C132H137ClF15N25O13 and a molecular weight of 2602.13 g/mol. Its IUPAC name is N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID165047205
Molecular FormulaC132H137ClF15N25O13
Molecular Weight2602.13 g/mol
Exact Mass2600.03
IUPAC NameN-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)ccc3n2)C1.CC(C)(O)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(Cl)cc3n2)C1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)c1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cnn2cccnc12.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CC(CO)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C24H26F3N3O2.C23H26N6O2.C22H23F3N4O3.C22H23F3N4O.C21H20ClF3N4O2.C20H19F3N4O3/c1-23(2,3)17-10-18(11-17)30-13-15-9-20(21(32-4)12-19(15)29-30)28-22(31)14-6-5-7-16(8-14)24(25,26)27;1-23(2,3)15-9-16(10-15)29-13-14-8-19(20(31-4)11-18(14)27-29)26-22(30)17-12-25-28-7-5-6-24-21(17)28;1-21(2,31)13-8-14(9-13)29-11-12-7-17(18(32-3)10-16(12)28-29)27-20(30)15-5-4-6-19(26-15)22(23,24)25;1-21(2,3)14-10-16(11-14)29-12-13-9-15(7-8-17(13)28-29)26-20(30)18-5-4-6-19(27-18)22(23,24)25;1-20(2,31)12-7-13(8-12)29-10-11-6-17(14(22)9-16(11)28-29)27-19(30)15-4-3-5-18(26-15)21(23,24)25;1-30-17-8-15-12(9-27(26-15)13-5-11(6-13)10-28)7-16(17)25-19(29)14-3-2-4-18(24-14)20(21,22)23/h5-9,12-13,17-18H,10-11H2,1-4H3,(H,28,31);5-8,11-13,15-16H,9-10H2,1-4H3,(H,26,30);4-7,10-11,13-14,31H,8-9H2,1-3H3,(H,27,30);4-9,12,14,16H,10-11H2,1-3H3,(H,26,30);3-6,9-10,12-13,31H,7-8H2,1-2H3,(H,27,30);2-4,7-9,11,13,28H,5-6,10H2,1H3,(H,25,29)
InChIKeyPCDIPBMXUUSYFU-UHFFFAOYSA-N
XLogP29.52
TPSA460.88 Ų
H-Bond Donors9
H-Bond Acceptors32
Rotatable Bonds25
Heavy Atoms186
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002602.13
LogP ≤ 529.52
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1032

Analyze N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 165047205) is N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is CC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)ccc3n2)C1.CC(C)(O)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(Cl)cc3n2)C1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)c1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cnn2cccnc12.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CC(CO)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.
What is the InChIKey of N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is PCDIPBMXUUSYFU-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26F3N3O2.C23H26N6O2.C22H23F3N4O3.C22H23F3N4O.C21H20ClF3N4O2.C20H19F3N4O3/c1-23(2,3)17-10-18(11-17)30-13-15-9-20(21(32-4)12-19(15)29-30)28-22(31)14-6-5-7-16(8-14)24(25,26)27;1-23(2,3)15-9-16(10-15)29-13-14-8-19(20(31-4)11-18(14)27-29)26-22(30)17-12-25-28-7-5-6-24-21(17)28;1-21(2,31)13-8-14(9-13)29-11-12-7-17(18(32-3)10-16(12)28-29)27-20(30)15-5-4-6-19(26-15)22(23,24)25;1-21(2,3)14-10-16(11-14)29-12-13-9-15(7-8-17(13)28-29)26-20(30)18-5-4-6-19(27-18)22(23,24)25;1-20(2,31)12-7-13(8-12)29-10-11-6-17(14(22)9-16(11)28-29)27-19(30)15-4-3-5-18(26-15)21(23,24)25;1-30-17-8-15-12(9-27(26-15)13-5-11(6-13)10-28)7-16(17)25-19(29)14-3-2-4-18(24-14)20(21,22)23/h5-9,12-13,17-18H,10-11H2,1-4H3,(H,28,31);5-8,11-13,15-16H,9-10H2,1-4H3,(H,26,30);4-7,10-11,13-14,31H,8-9H2,1-3H3,(H,27,30);4-9,12,14,16H,10-11H2,1-3H3,(H,26,30);3-6,9-10,12-13,31H,7-8H2,1-2H3,(H,27,30);2-4,7-9,11,13,28H,5-6,10H2,1H3,(H,25,29).
What are the key properties of N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 2602.13 g/mol, XLogP of 29.52, 25 rotatable bonds, 9 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 165047205), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).